This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Rexulti 1 mg tablets to the U.S. government. The contract, valued at $3,102.97, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. Amerisourcebergen is a major pharmaceutical distribution company that provides a wide range of medical products and supplies to various federal agencies, particularly the Department of Defense (DoD) and Veterans Affairs (VA). This contract does not have a set-aside designation.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Generated 9/26/24, 9:38 AM